Angiogenesis

Bevacizumab plus Irinotecan, Fluorouracil, and Leucovorin for Metastatic Colorectal Cancer

Hurwitz, H., Fehrenbacher, L., Novotny, W., Cartwright, T., Hainsworth, J., Heim, W., Berlin, J., Baron, A., Griffing, S., Holmgren, E., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032691 · Cited by 10,968 · see citing works

Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis

Hanahan, D., & Folkman, J. (1996) · Cell · doi:10.1016/s0092-8674(00)80108-7 · Cited by 6,885 · see citing works

Endostatin: an endogenous inhibitor of angiogenesis and tumor growth

O'Reilly, M. S., Boehm, T., Shing, Y., Fukai, N., Vasios, G., Lane, W. S., Flynn, E., Birkhead, J. R., Olsen, B. R., & Folkman, J. (1997) · Cell · doi:10.1016/s0092-8674(00)81848-6 · Cited by 4,486 · see citing works

Vascular Endothelial Growth Factor: Basic Science and Clinical Progress

Ferrara, N. (2004) · Endocrine Reviews · doi:10.1210/er.2003-0027 · Cited by 3,707 · see citing works

Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a lewis lung carcinoma

OʼReilly, M. (1994) · Cell · doi:10.1016/0092-8674(94)90200-3 · Cited by 3,344 · see citing works

Transplacental Carcinogenesis by Stilbestrol

Folkman, J. (1971) · New England Journal of Medicine · doi:10.1056/nejm197108122850711 · Cited by 2,640 · see citing works

Thalidomide is an inhibitor of angiogenesis.

D'Amato, R. J., Loughnan, M. S., Flynn, E., & Folkman, J. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.9.4082 · Cited by 2,454 · see citing works

Dormancy of micrometastases: Balanced proliferation and apoptosis in the presence of angiogenesis suppression

Holmgren, L., O’Reilly, M. S., & Folkman, J. (1995) · Nature Medicine · doi:10.1038/nm0295-149 · Cited by 1,870 · see citing works

Impaired recruitment of bone-marrow–derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth

Lyden, D., Hattori, K., Dias, S., Costa, C., Blaikie, P., Butros, L., Chadburn, A., Heissig, B., Marks, W., Witte, L., et al. (2001) · Nature Medicine · doi:10.1038/nm1101-1194 · Cited by 1,860 · see citing works

Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance

Boehm, T., Folkman, J., Browder, T., & O'Reilly, M. S. (1997) · Nature · doi:10.1038/37126 · Cited by 1,683 · see citing works

Control of Angiogenesis in Fibroblasts by p53 Regulation of Thrombospondin-1

Dameron, K. M., Volpert, O. V., Tainsky, M. A., & Bouck, N. (1994) · Science · doi:10.1126/science.7521539 · Cited by 1,437 · see citing works

The anti-angiogenic basis of metronomic chemotherapy

Kerbel, R. S., & Kamen, B. A. (2004) · Nature reviews. Cancer · doi:10.1038/nrc1369 · Cited by 1,396 · see citing works

Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumour growth

Ingber, D. E., Fujita, T., KISHIMOTO, S., Sudo, K., KANAMARU, T., Brem, H., & Folkman, J. (1990) · Nature · doi:10.1038/348555a0 · Cited by 1,292 · see citing works

Continuous low-dose therapy with vinblastine and VEGF receptor-2 antibody induces sustained tumor regression without overt toxicity

Klement, G. L., Baruchel, S., Rak, J. W., Man, S., Clark, K., Hicklin, D. J., Böhlen, P., & Kerbel, R. S. (2000) · Journal of Clinical Investigation · doi:10.1172/jci8829 · Cited by 1,166 · see citing works

Regulation of tumor angiogenesis by p53-induced degradation of hypoxia-inducible factor 1α

Ravi, R., Mookerjee, B., Bhujwalla, Z. M., Sutter, C. H., Artemov, D., Zeng, Q., Dillehay, L. E., Madan, A., Semenza, G. L., & Bedi, A. (2000) · Genes & Development · doi:10.1101/gad.14.1.34 · Cited by 967 · see citing works

Essential role for oncogenic Ras in tumour maintenance

Chin, L., Tam, A., Pomerantz, J. H., Wong, M., Holash, J., Bardeesy, N., Shen, Q., O'Hagan, R., Pantginis, J., Zhou, H., et al. (1999) · Nature · doi:10.1038/22788 · Cited by 928 · see citing works

Reversible tumorigenesis by MYC in hematopoietic lineages.

Felsher, D., & Bishop, J. (1999) · Molecules and Cells · doi:10.1016/s1097-2765(00)80367-6 · Cited by 917 · see citing works

TUMOR DORMANCY IN VIVO BY PREVENTION OF NEOVASCULARIZATION

Gimbrone, M. A., Leapman, S. B., Cotran, R. S., & Folkman, J. (1972) · The Journal of Experimental Medicine · doi:10.1084/jem.136.2.261 · Cited by 903 · see citing works

Less is more, regularly: metronomic dosing of cytotoxic drugs can target tumor angiogenesis in mice

Hanahan, D., Bergers, G., & Bergsland, E. K. (2000) · Journal of Clinical Investigation · doi:10.1172/jci9872 · Cited by 868 · see citing works

Mortality associated with Down's syndrome in the USA from 1983 to 1997: a population-based study

Yang, Q., Rasmussen, S. A., & Friedman, J. M. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08092-3 · Cited by 847 · see citing works

Adipose tissue mass can be regulated through the vasculature

Rupnick, M. A., Panigrahy, D., Zhang, C.-Y., Dallabrida, S. M., Lowell, B. B., Langer, R., & Folkman, M. J. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.162349799 · Cited by 845 · see citing works

Angiogenesis Inhibitors Endostatin or TNP-470 Reduce Intimal Neovascularization and Plaque Growth in Apolipoprotein E–Deficient Mice

Moulton, K. S., Heller, E., Konerding, M. A., Flynn, E., Palinski, W., & Folkman, J. (1999) · Circulation · doi:10.1161/01.cir.99.13.1726 · Cited by 688 · see citing works

Missense mutations interfere with VEGFR-3 signalling in primary lymphoedema

Karkkainen, M. J., Ferrell, R. E., Lawrence, E., Kimak, M. A., Levinson, K. L., McTigue, M. A., Alitalo, K. K., & Finegold, D. N. (2000) · Nature Genetics · doi:10.1038/75997 · Cited by 644 · see citing works

Viral oncogenes

Bishop, J. M. (1985) · Cell · doi:10.1016/s0092-8674(85)80098-2 · Cited by 610 · see citing works

Protamine is an inhibitor of angiogenesis

Taylor, S., & Folkman, J. (1982) · Nature · doi:10.1038/297307a0 · Cited by 580 · see citing works

Physiological levels of tumstatin, a fragment of collagen IV α3 chain, are generated by MMP-9 proteolysis and suppress angiogenesis via αVβ3 integrin

Hamano, Y., Zeisberg, M., Sugimoto, H., Lively, J. C., Maeshima, Y., Yang, C., Hynes, R. O., Werb, Z., Sudhakar, A., & Kalluri, R. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00133-8 · Cited by 560 · see citing works

Endogenous Inhibitors of Angiogenesis

Nyberg, P., Xie, L., & Kalluri, R. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-2427 · Cited by 557 · see citing works

Advances in diagnostic imaging and overestimations of disease prevalence and the benefits of therapy

Black, W. C., & Welch, H. G. (1993) · New England Journal of Medicine · doi:10.1056/nejm199304293281706 · Cited by 547 · see citing works

Cancer without disease

Folkman, J., & Kalluri, R. (2004) · Nature · doi:10.1038/427787a · Cited by 521 · see citing works

A New Class of Steroids Inhibits Angiogenesis in the Presence of Heparin or a Heparin Fragment

Crum, R. M., Szabó, S., & Folkman, J. (1985) · Science · doi:10.1126/science.2416056 · Cited by 489 · see citing works

Human tumstatin and human endostatin exhibit distinct antiangiogenic activities mediated by αvβ3 and α5β1 integrins

Sudhakar, A., Sugimoto, H., Yang, C., Lively, J. C., Zeisberg, M., & Kalluri, R. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0730882100 · Cited by 486 · see citing works

Secreted cathepsin L generates endostatin from collagen XVIII

Felbor, U., Dreier, L., Bryant, R. A. R., Ploegh, H. L., Olsen, B. R., & Mothes, W. (2000) · The EMBO Journal · doi:10.1093/emboj/19.6.1187 · Cited by 470 · see citing works

Oncogenic H-ras stimulates tumor angiogenesis by two distinct pathways

Arbiser, J. L., Moses, M. A., Fernández, C. A., Ghiso, N., Cao, Y., Klauber, N., Frank, D. A., Brownlee, M., Flynn, E. A., Parangi, S., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.3.861 · Cited by 466 · see citing works

Methionine aminopeptidase (type 2) is the common target for angiogenesis inhibitors AGM-1470 and ovalicin

Griffith, E. C., Su, Z., Turk, B. E., Chen, S., Chang, Y., Wu, Z., BIEMANN, K., & Liu, J. O. (1997) · Chemistry & Biology · doi:10.1016/s1074-5521(97)90198-8 · Cited by 421 · see citing works

Thrombospondin 1, a mediator of the antiangiogenic effects of low-dose metronomic chemotherapy

Bocci, G., Francia, G., Man, S., Lawler, J., & Kerbel, R. S. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2135406100 · Cited by 413 · see citing works

Endostatin's Antiangiogenic Signaling Network

Abdollahi, A., Hahnfeldt, P., Maercker, C., Gröne, H., Debus, J., Ansorge, W. J., Folkman, J., Hlatky, L., & Huber, P. E. (2004) · Molecular Cell · doi:10.1016/s1097-2765(04)00102-9 · Cited by 393 · see citing works

Distinct Antitumor Properties of a Type IV Collagen Domain Derived from Basement Membrane

Maeshima, Y., Colorado, P. C., de la Torre, A., Holthaus, K. A., Grunkemeyer, J. A., Ericksen, M. B., Hopfer, H., Xiao, Y., Stillman, I. E., & Kalluri, R. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m001956200 · Cited by 358 · see citing works

Targeting angiogenesis with a conjugate of HPMA copolymer and TNP-470

Satchi‐Fainaro, R., Puder, M., Davies, J. W., Tran, H. T., Sampson, D. A., Greene, A. K., Corfas, G., & Folkman, J. (2004) · Nature Medicine · doi:10.1038/nm1002 · Cited by 345 · see citing works

Mutations in a Novel Factor, Glomulin, Are Responsible for Glomuvenous Malformations (“Glomangiomas”)

Brouillard, P., Boon, L. M., Mulliken, J. B., et al. (2002) · The American Journal of Human Genetics · doi:10.1086/339492 · Cited by 343 · see citing works

Genetic heterogeneity of the vasculogenic phenotype parallels angiogenesis

Shaked, Y., Bertolini, F., Man, S., Rogers, M. S., Cervi, D., Foutz, T. J., Rawn, K., Voskas, D., Dumont, D., Ben‐David, Y., et al. (2005) · Cancer Cell · doi:10.1016/j.ccr.2004.11.023 · Cited by 329 · see citing works

Inhibition of Cell Motility by Interferon

Brouty‐Boyé, D., & Zetter, B. R. (1980) · Science · doi:10.1126/science.6154315 · Cited by 328 · see citing works

Identification of an angiogenic factor that when mutated causes susceptibility to Klippel–Trenaunay syndrome

Tian, X., Kadaba, R., You, S.-A., et al. (2004) · Nature · doi:10.1038/nature02320 · Cited by 322 · see citing works

Endogenous angiogenesis inhibitors

Folkman, J. (2004) · Apmis · doi:10.1111/j.1600-0463.2004.apm11207-0809.x · Cited by 321 · see citing works

Thrombospondin-2: A potent endogenous inhibitor of tumor growth and angiogenesis

Streit, M., Riccardi, L., Velasco, P., Brown, L. F., Hawighorst, T., BORNSTEIN, P. K., & Detmar, M. J. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.26.14888 · Cited by 303 · see citing works

Comparative evaluation of the antitumor activity of antiangiogenic proteins delivered by gene transfer

Kuo, C. J., Farnebo, F. A., Yu, E. Y., Christofferson, R. H. B., Swearingen, R. A., Carter, R., von Recum, H. A., Yuan, J., Kamihara, J., Flynn, E. A., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.081615298 · Cited by 268 · see citing works

Antiangiogenic Therapy of a Recurrent Giant Cell Tumor of the Mandible With Interferon Alfa-2a

Kaban, L. B., Mulliken, J. B., Ezekowitz, R. A. B., Phil, D., Ebb, D. H., Smith, P. S., & Folkman, J. (1999) · PEDIATRICS · doi:10.1542/peds.103.6.1145 · Cited by 245 · see citing works

ADAM 12 Cleaves Extracellular Matrix Proteins and Correlates with Cancer Status and Stage

Roy, R., Wewer, U. M., Zurakowski, D., Pories, S. E., & Moses, M. A. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m409565200 · Cited by 244 · see citing works

Genetic heterogeneity of angiogenesis in mice

Rohan, R. M., Fernandez-Perez, A., Udagawa, T., Yuan, J., & D’Amato, R. J. (2000) · The FASEB Journal · doi:10.1096/fasebj.14.7.871 · Cited by 211 · see citing works

Antiangiogenesis signals by endostatin

Shichiri, M., & Hirata, Y. (2001) · The FASEB Journal · doi:10.1096/fj.99-1083com · Cited by 206 · see citing works

A Feasibility Trial of Antiangiogenic (Metronomic) Chemotherapy in Pediatric Patients With Recurrent or Progressive Cancer

Kieran, M. W., Turner, C. D., Rubin, J. B., Chi, S. N., Zimmerman, M. A., Chordas, C. A., Klement, G. L., Laforme, A., Gordon, A., Thomas, A., et al. (2005) · Journal of Pediatric Hematology/Oncology · doi:10.1097/01.mph.0000183863.10792.d4 · Cited by 199 · see citing works

Microvascular Injury in Pathogenesis of Interferon-Induced Necrosis of Subcutaneous Tumors in Mice

Dvorak, H. F., & Gresser, I. (1989) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/81.7.497 · Cited by 192 · see citing works

Thrombospondin-1 Associated with Tumor Microenvironment Contributes to Low-Dose Cyclophosphamide-Mediated Endothelial Cell Apoptosis and Tumor Growth Suppression

Hamano, Y., Sugimoto, H., Soubasakos, M. A., Kieran, M. W., Olsen, B. R., Lawler, J., Sudhakar, A., & Kalluri, R. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3126 · Cited by 185 · see citing works

Function of endogenous inhibitors of angiogenesis as endothelium-specific tumor suppressors

Sund, M., Hamano, Y., Sugimoto, H., Sudhakar, A., Soubasakos, M. A., Yerramalla, U. L., Benjamin, L. E., Lawler, J., Kieran, M. W., Shah, A. J., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0500180102 · Cited by 182 · see citing works

Inhibition of vessel permeability by TNP-470 and its polymer conjugate, caplostatin

Satchi‐Fainaro, R., Mamluk, R., Wang, X., Short, S. M., Nagy, J. A., Feng, D., Dvořàk, A. M., Dvorak, H. F., Puder, M., Mukhopadhyay, D., et al. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.02.007 · Cited by 173 · see citing works

Loss of Collagen XVIII Enhances Neovascularization and Vascular Permeability in Atherosclerosis

Moulton, K. S., Olsen, B. R., Sonn, S., Fukai, N., Zurakowski, D., & Zeng, X. (2004) · Circulation · doi:10.1161/01.cir.0000140720.79015.3c · Cited by 152 · see citing works

High serum endostatin levels in Down syndrome: implications for improved treatment and prevention of solid tumours

Zorick, T. S., Mustacchi, Z., Bando, S. Y., Zatz, M., Moreira‐Filho, C. A., Olsen, B. R., & Passos‐Bueno, M. R. (2001) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5200721 · Cited by 148 · see citing works

Persistence of microscopic human cancers in mice: alterations in the angiogenic balance accompanies loss of tumor dormancy

Udagawa, T., Fernández, A., Achilles, E., Folkman, J., & D’Amato, R. J. (2002) · The FASEB Journal · doi:10.1096/fj.01-0813com · Cited by 147 · see citing works

Thalidomide-induced antiangiogenic action is mediated by ceramide through depletion of VEGF receptors, and is antagonized by sphingosine-1-phosphate

Yabu, T., Tomimoto, H., Taguchi, Y., Yamaoka, S., Igarashi, Y., & Okazaki, T. (2005) · Blood · doi:10.1182/blood-2004-09-3679 · Cited by 136 · see citing works

Zinc-dependent dimers observed in crystals of human endostatin

Ding, Y., Javaherian, K., Lo, K.-M., Chopra, R., Boehm, T., Lanciotti, J., Harris, B. A., Li, Y., Shapiro, R., Hohenester, E., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.18.10443 · Cited by 130 · see citing works

Therapeutic Efficacy of Endostatin Exhibits a Biphasic Dose-Response Curve

Celik, I., Sürücü, O., Dietz, C., Heymach, J. V., Force, J. M., Höschele, I., Becker, C. M., Folkman, J., & Kisker, O. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-2617 · Cited by 129 · see citing works

c-Myc Interacts with Hypoxia to Induce Angiogenesis In vivo by a Vascular Endothelial Growth Factor-Dependent Mechanism

Knies, U. E., Fox, S. B., Poulsom, R., Evan, G. I., & Harris, A. L. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3176 · Cited by 121 · see citing works

A 27-Amino-Acid Synthetic Peptide Corresponding to the NH2-Terminal Zinc-Binding Domain of Endostatin Is Responsible for Its Antitumor Activity

Sjin, R. M. T. T., Satchi‐Fainaro, R., Birsner, A. E., Ramanujam, V. M. S., Folkman, J., & Javaherian, K. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-1833 · Cited by 106 · see citing works

Heterogeneity of Angiogenic Activity in a Human Liposarcoma: a Proposed Mechanism for "No Take" of Human Tumors in Mice

Achilles, E. G., Fernandez, A., Allred, E. N., Kisker, O., Udagawa, T., Beecken, W.-D., Flynn, E. A., & Folkman, J. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.14.1075 · Cited by 100 · see citing works

Cost-Utility Analysis of Preoperative Radiotherapy in Patients With Rectal Cancer Undergoing Total Mesorectal Excision: A Study of the Dutch Colorectal Cancer Group

van den Brink, M., van den Hout, W. B., Stiggelbout, A. M., Kranenbarg, E. M., Marijnen, C. A. M., van de Velde, C. J. �., & Kievit, J. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2004.04.198 · Cited by 99 · see citing works

Angiogenic Potential of Prostate Carcinoma Cells Overexpressing bcl-2

Fernandez, A., Udagawa, T., Meyer‐Schwesinger, C., Beecken, W.-D., Achilles-Gerte, E., McDonnell, T. J., & D’Amato, R. J. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.3.208 · Cited by 99 · see citing works

Knobloch syndrome: Novel mutations inCOL18A1, evidence for genetic heterogeneity, and a functionally impaired polymorphism in endostatin

Menzel, O., Bekkeheien, R. C. J., Reymond, A., et al. (2003) · Human Mutation · doi:10.1002/humu.10284 · Cited by 95 · see citing works

Incipient Angiogenesis

Folkman, J. (2000) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/92.2.94 · Cited by 90 · see citing works

Successful Antiangiogenic Therapy of Giant Cell Angioblastoma With Interferon Alfa 2b: Report of 2 Cases

Marler, J. J., Rubin, J. B., Trede, N. S., et al. (2002) · PEDIATRICS · doi:10.1542/peds.109.2.e37 · Cited by 78 · see citing works

Pulmonary Capillary Hemangiomatosis With Atypical Endotheliomatosis *

Ginns, L. C., Roberts, D. H., Mark, E. J., Brusch, J. L., & Marler, J. J. (2003) · CHEST Journal · doi:10.1378/chest.124.5.2017 · Cited by 62 · see citing works

IS ABSENCE OF ATHEROMA IN DOWN SYNDROME DUE TO DECREASED HOMOCYSTEINE LEVELS?

Chadefaux, B., Ceballos-Picot, I., Hamet, M., Coudé, M.-M., Poissonnier, M., Kamoun, P., & Allard, D. (1988) · The Lancet · doi:10.1016/s0140-6736(88)90211-5 · Cited by 61 · see citing works

Induction of therapeutic antitumor antiangiogenesis by intratumoral injection of genetically engineered endostatin-producing Semliki Forest virus

Yamanaka, R., Zullo, S. A., Ramsey, J., Onodera, M., Tanaka, R., Blaese, M. R., & Xanthopoulos, K. G. (2001) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7700367 · Cited by 61 · see citing works

Endostatin therapy reveals a U-shaped curve for antitumor activity

Sjin, R. M. T. T., Naspinski, J., Birsner, A. E., Li, C., Chan, R., Lo, K.-M., Gillies, S. D., Zurakowski, D., Folkman, J., Samulski, J. R., et al. (2006) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7700938 · Cited by 61 · see citing works

Endostatin binds biglycan and LDL and interferes with LDL retention to the subendothelial matrix during atherosclerosis

Zeng, X., Chen, J., Miller, Y. I., Javaherian, K., & Moulton, K. S. (2005) · Journal of Lipid Research · doi:10.1194/jlr.m500241-jlr200 · Cited by 57 · see citing works

Unfulfilled Promise of Endostatin in a Gene Therapy-Xenotransplant Model of Human Acute Lymphocytic Leukemia

Eisterer, W., Jiang, X., Bachelot, T., Pawliuk, R., Abramovich, C., Leboulch, P., Hogge, D. E., & Eaves, C. J. (2002) · Molecular Therapy · doi:10.1006/mthe.2002.0573 · Cited by 57 · see citing works

The Breast: Comprehensive Management of Benign and Malignant Disorders.

Furnival, C. M. (2004) · ANZ Journal of Surgery · doi:10.1111/j.1445-1433.2004.03274.x · Cited by 56 · see citing works

Effect of Retroviral Endostatin Gene Transfer on Subcutaneous and Intraperitoneal Growth of Murine Tumors

Feldman, A. L., Alexander, H. R., Hewitt, S. M., et al. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.13.1014 · Cited by 49 · see citing works

Downmodulation of bFGF-binding protein expression following restoration of p53 function

Sherif, Z. A., Nakai, S., Pirollo, K. F., Rait, A. S., & Chang, E. H. (2001) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7700361 · Cited by 45 · see citing works

PPARγ ligands inhibit primary tumor growth and metastasis by inhibiting angiogenesis

Panigrahy, D., Singer, S., Shen, L. Q., Butterfield, C., Freedman, D. A., Chen, E. J., Moses, M. A., Kilroy, S. M., Duensing, S. M., Fletcher, C. D. �., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci200215634 · Cited by 42 · see citing works

Binding of endostatin to endothelial heparan sulphate shows a differential requirement for specific sulphates

Blackhall, F. H., Merry, C. L. R., Lyon, M., et al. (2003) · Biochemical Journal · doi:10.1042/bj20030730 · Cited by 40 · see citing works

Diabetic retinopathy in Down's syndrome

Fulcher, T., Griffin, M., Crowley, S., et al. (1998) · British Journal of Ophthalmology · doi:10.1136/bjo.82.4.407 · Cited by 35 · see citing works

Targeted Therapies in Rheumatology

Bresnihan, B. (2004) · Annals of Internal Medicine · doi:10.7326/0003-4819-140-2-200401200-00035 · Cited by 34 · see citing works

Genotype Association of C(-735)T Polymorphism in Matrix Metalloproteinase 2 Gene with G(8002)A Endothelin 1 Gene with Plaque Psoriasis

Vašků, V., Vašků, A., Tschöplová, S., et al. (2002) · Dermatology · doi:10.1159/000063355 · Cited by 27 · see citing works

Early Tumor Detection Using Platelet Uptake of Angiogenesis Regulators.

Klement, G. L., Kikuchi, L., Kieran, M. W., et al. (2004) · Blood · doi:10.1182/blood.v104.11.839.839 · Cited by 22 · see citing works

Effects of Thalidomide on Parameters Involved in Angiogenesis: An in vitro Study

Gelati, M., Corsini, E., Frigerio, S., et al. (2003) · Journal of Neuro-Oncology · doi:10.1023/a:1025618022921 · Cited by 21 · see citing works

Editorial: Is Tissue Mass Regulated by Vascular Endothelial Cells? Prostate as the First Evidence

Folkman, J. (1998) · Endocrinology · doi:10.1210/en.139.2.441 · Cited by 20 · see citing works

Starving Tumors of Their Lifeblood

Ezzell, C. (1998) · Scientific American · doi:10.1038/scientificamerican1098-33 · Cited by 19 · see citing works

TNP-470

Milkowski, D. M., & Weiss, R. A. (1999) · Humana Press eBooks · doi:10.1007/978-1-59259-453-5_22 · Cited by 6 · see citing works

Hallmarks of Cancer: The Next Generation

Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590 · see citing works

Benefaction of probiotics for human health: A review

George Kerry, R., Patra, J. K., Gouda, S., Park, Y., Shin, H.-S., & Das, G. (2018) · Journal of Food and Drug Analysis · doi:10.1016/j.jfda.2018.01.002 · Cited by 898 · see citing works

Antiangiogenic Agents Can Increase Lymphocyte Infiltration into Tumor and Enhance the Effectiveness of Adoptive Immunotherapy of Cancer

Shrimali, R. K., Yu, Z., Theoret, M. R., Chinnasamy, D., Restifo, N. P., & Rosenberg, S. A. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-0153 · Cited by 677 · see citing works

The role of stroma in pancreatic cancer: Diagnostic and therapeutic implications

Erkan, M., Hausmann, S., Michalski, C. W., Fingerle, A. A., Dobritz, M., Kleeff, J., & Friess, H. (2012) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2012.115 · Cited by 662 · see citing works

Polymeric nanomedicine for cancer therapy

Park, J. H., Lee, S., Kim, J.-H., Park, K., Kim, K., & Kwon, I. C. (2008) · Progress in Polymer Science · doi:10.1016/j.progpolymsci.2007.09.003 · Cited by 506 · see citing works

CCN1/CYR61: the very model of a modern matricellular protein

Lau, L. F. (2011) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-011-0778-3 · Cited by 338 · see citing works

Novel anti-angiogenic therapies for malignant gliomas

Norden, A. D., Drappatz, J., & Wen, P. Y. (2008) · The Lancet Neurology · doi:10.1016/s1474-4422(08)70260-6 · Cited by 246 · see citing works

Update of probiotics in human world: A nonstop source of benefactions till the end of time

Zommiti, M., Feuilloley, M. G. J., & Connil, N. (2020) · Microorganisms · doi:10.3390/microorganisms8121907 · Cited by 225 · see citing works

Endometriosis: The Role of Neuroangiogenesis

Asante, A., & Taylor, R. N. (2011) · Annual Review of Physiology · doi:10.1146/annurev-physiol-012110-142158 · Cited by 223 · see citing works

Cancer combination therapies by angiogenesis inhibitors; a comprehensive review

Ansari, M. J., Bokov, D., Markov, A., Jalil, A. T., Shalaby, M. N., Suksatan, W., Chupradit, S., AL-Ghamdi, H. S., Shomali, N., Zamani, A., et al. (2022) · Cell Communication and Signaling · doi:10.1186/s12964-022-00838-y · Cited by 197 · see citing works

Ets1 and ets2 are required for endothelial cell survival during embryonic angiogenesis

Wei, G., Srinivasan, R., Cantemir-Stone, C. Z., Sharma, S. M., Santhanam, R., Weinstein, M., Muthusamy, N., Man, A. K., Oshima, R. G., Leone, G., et al. (2009) · Blood · doi:10.1182/blood-2009-03-211391 · Cited by 185 · see citing works

Targeting Vascular NADPH Oxidase 1 Blocks Tumor Angiogenesis through a PPARα Mediated Mechanism

Garrido-Urbani, S., Jemelin, S., Deffert, C., Carnesecchi, S., Basset, O., Szyndralewiez, C., Heitz, F., Page, P., Montet, X., Michalik, L., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0014665 · Cited by 143 · see citing works

Targeting activin receptor-like kinase 1 inhibits angiogenesis and tumorigenesis through a mechanism of action complementary to anti-VEGF therapies

Hu-Lowe, D. D., Chen, E., Zhang, L., Watson, K. D., Mancuso, P., Lappin, P., Wickman, G., Chen, J. H., Wang, J., Jiang, X., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-1451 · Cited by 130 · see citing works

The Fluid Mechanics of Cancer and Its Therapy

Koumoutsakos, P., Pivkin, I., & Milde, F. (2013) · Annual Review of Fluid Mechanics · doi:10.1146/annurev-fluid-120710-101102 · Cited by 129 · see citing works

Elimination of Neoangiogenesis for Plaque Stabilization

Kolodgie, F. D., Narula, J., Yuan, C., Burke, A. P., Finn, A. V., & Virmani, R. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.10.083 · Cited by 96 · see citing works

Jumping the barrier: VE‐cadherin, VEGF and other angiogenic modifiers in cancer

Le Guelte, A., Dwyer, J., & Gavard, J. (2011) · Biology of the Cell · doi:10.1042/bc20110069 · Cited by 91 · see citing works

Marine-derived angiogenesis inhibitors for cancer therapy

Wang, Y.-Q., & Miao, Z.-H. (2013) · Marine Drugs · doi:10.3390/md11030903 · Cited by 72 · see citing works

Lack of thrombospondin 1 and exacerbation of choroidal neovascularization

Wang, S., Sorenson, C. M., & Sheibani, N. (2012) · Archives of Ophthalmology · doi:10.1001/archopthalmol.2011.1892 · Cited by 61 · see citing works

HDAC in obesity: A critical insight

Nijhawan, P., Behl, T., Khullar, G., Pal, G., Kandhwal, M., & Goyal, A. (2020) · Obesity Medicine · doi:10.1016/j.obmed.2020.100212 · Cited by 13 · see citing works

Suppression of thrombospondin-1 expression during uveal melanoma progression and its potential therapeutic utility

Wang, S. (2012) · Archives of Ophthalmology · doi:10.1001/archopthalmol.2011.1503 · Cited by 19 · see citing works

Vascular-specific quantification in an in vivo Matrigel chamber angiogenesis assay

Baker, J. H. E., Huxham, L. A., Kyle, A. H., Lam, K. K., & Minchinton, A. I. (2006) · Microvascular Research · doi:10.1016/j.mvr.2006.01.002 · Cited by 21 · see citing works

Drug Ratio-Dependent Antagonism: A New Category of Multidrug Resistance and Strategies for Its Circumvention

Harasym, T. O., Liboiron, B. D., & Mayer, L. D. (2009) · Methods in molecular biology · doi:10.1007/978-1-60761-416-6_13 · Cited by 39 · see citing works

MiRNA-29b suppresses tumor growth through simultaneously inhibiting angiogenesis and tumorigenesis by targeting Akt3

Li, Y., Cai, B., Shen, L., et al. (2017) · Cancer Letters · doi:10.1016/j.canlet.2017.03.032 · Cited by 128 · see citing works

MicroRNA‑218 inhibits tumor angiogenesis of human renal cell carcinoma by targeting GAB2

Mu, L., Guan, B., Tian, J., et al. (2020) · Oncology Reports · doi:10.3892/or.2020.7759 · Cited by 12 · see citing works

[Inhibitory effect of oxaliplatin in combination with hyperthermia on angiogenesis].

Qian, X., Liu, B., Li, M., et al. (2007) · PubMed · Cited by 3 · see citing works